Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03948282 · ClinicalTrials.gov registry record
Ultrasound Assessment of the Inferior Vena Cava in Children
A clinical trial, sponsored by Alok Moharir.
- Completed
- Registry status
- 51
- Enrollment target
NCT03948282: Completed study, sponsored by Alok Moharir.
NCT03948282 is a clinical trial that has completed, run by Alok Moharir. The registered enrollment target is 51 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03948282 has completed, sponsored by Alok Moharir.
- COMPLETED
- Registry status
- 51 participants
- Enrollment target
Study Summary
This is a prospective, non-blinded observational study to compare measurement of inferior vena cava (IVC) dimensions with two placement sites of the ultrasound probe (sub-xiphoid and the side or right lateral position).
Primary Outcome
Measurement of the inferior vena cava via ultrasound using the right lateral view and the subxiphoid view.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2019-07-31 |
| Est. Completion | 2019-08-16 |
What the finished NCT03948282 record still lists
NCT03948282 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 51 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT03948282 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03948282 about?
NCT03948282 is a clinical study titled "Ultrasound Assessment of the Inferior Vena Cava in Children". This is a prospective, non-blinded observational study to compare measurement of inferior vena cava (IVC) dimensions with two placement sites of the ultrasound probe (sub-xiphoid and the side or right lateral position).
What is the current status of trial NCT03948282?
This trial is currently completed. The enrollment target is 51 participants. The study started on 2019-07-31. Estimated completion is 2019-08-16.
Who is sponsoring clinical trial NCT03948282?
This trial is sponsored by Alok Moharir, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02701153 · 51 participants · NA
Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort
- NCT03663790 · 51 participants · NA
Effects of Gait Retraining on Lower Extremity Biomechanics
- NCT03874052 · 51 participants · Phase 1
Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- NCT04704661 · 51 participants · Phase 1
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI